2022/04/13
Announcement of Joint Research Agreement Regarding New Therapeutic Approach against Cardiovascular Diseases
2021/09/03
Announcement of New Chief Technology Officer (CTO): Pro. Yoshiki Sawa
2021/03/16
Private Placement of New Shares
2020/12/04
2020/09/23
Cuorips officially commenced operations at its new state-of-the-art commercial cell processing facility
2020/03/02
Cuorips Started Construction of Cell Culture Processing Facility for Commercial Production
2018/07/11
Announcement of Third-Party Allocation of New Shares